Transplantation of Reprogrammed Autologous Stem Cells for Chronic Pain and Drug Abuse
Abstract
This project is a Partnering PI option with Dr. Jianguo Cheng at CCF as Initiating PI and Dr. Tingyu Qu at UIC as Partnering PI. The specific aims are to generate functional chromaffin-like cells from mesenchymal stem cells (MSCs) and to investigate the analgesic and anti-tolerance effects and the safety of chromaffin-like cells in animal models. We have conducted the proposed experiments as outlined in SOW. Specifically, we have produced chromaffin-like cells by reprogramming human MSCs (hMSCs) with the extracts of porcine adrenal chromaffin cells. We have harvested bone marrow tissues from rats and isolated, cultured, and expanded rat MSCs (rMSCs) for the targeted reprogramming by using cellular extracts of porcine adrenal chromaffin cells to produce chromaffin-like cells. Recently, we found that even na ve MSCs at their early passages (<passage 5) had significant analgesic and robust anti-tolerance effects in both cellular and animal models. Our research has led to one poster presentation at conference, one patent application, and one manuscript in preparation in the second year of this 3 year project.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2013
- Accession Number
- ADA599259
Entities
People
- Tingyu Qu
Organizations
- University of Chicago